Gvoke HypoPen

Indicated For

Severe hypoglycemia, very low blood sugar

About This Medication

# Gvoke HypoPen Patient Guide: How to Get Gvoke HypoPen at Low or No Cost Gvoke HypoPen (glucagon injection) is a life-saving emergency treatment for severe hypoglycemia in people with diabetes. The **Gvoke Patient Assistance Program** from **Xeris** helps **uninsured or underinsured patients** who can't afford their medication get it at low or no cost by calling **1-877-694-8653**. ## About Gvoke HypoPen **Gvoke HypoPen** is a ready-to-use, prefilled syringe delivering **glucagon injection**, a hormone that quickly raises blood sugar during severe low blood sugar (hypoglycemia) episodes when someone is unconscious or unable to swallow. Unlike older glucagon kits requiring mixing, Gvoke HypoPen is user-friendly for caregivers—no reconstitution needed. It's FDA-approved for adults and children 2 years and older with diabetes. Administer by pressing against the thigh; effects start in 15 minutes. Always seek medical help after use. Common side effects include nausea and vomiting[1]. ## Who Qualifies for the Program? This program targets **uninsured or underinsured patients** facing affordability barriers. Exact income limits aren't detailed publicly, so eligibility depends on case-by-case review. Likely prioritizes those with household incomes below a certain federal poverty level (FPL) percentage, though specifics require contacting the program. U.S. residents with a valid prescription qualify if they meet financial criteria. Not for patients with government insurance like Medicare unless underinsured. ## Income Eligibility Breakdown Detailed income thresholds aren't specified in available sources. Contact the program for personalized assessment. Here's a general table based on typical patient assistance structures (confirm with Xeris): | Household Size | Estimated Max Income (300% FPL example)* | |----------------|-----------------------------------------| | 1 (Individual) | $45,180 | | 2 (Couple) | $61,320 | | 3 | $77,460 | | 4 | $93,600 | *Hypothetical based on 2026 FPL; actual criteria may vary. Notes: "Eligibility criteria not specified in available sources." Call **1-877-694-8653** for exact guidelines. ## Insurance Requirements Designed for **uninsured or underinsured patients who cannot afford medication**. Commercially insured patients may use a separate **$0 copay card** if Gvoke is covered (even without prior authorization)[1]. Medicare, Medicaid, or other federal program patients typically ineligible for free medication but may qualify for copay help. Verify status when applying. ## Step-by-Step Application Process 1. **Get a Prescription**: Ask your doctor for Gvoke HypoPen prescription. 2. **Gather Info**: Prepare proof of income (tax returns, pay stubs), prescription, proof of residency, and insurance details (if any). 3. **Call the Program**: Dial **1-877-694-8653** (application by phone only). Provide patient details, financial info, and prescriber contact. 4. **Submit Documents**: Fax/email as requested (none specified upfront). 5. **Wait for Approval**: Program reviews; you'll get a decision. 6. **Receive Medication**: If approved, shipped to you or pharmacy. Application is straightforward via phone—staff guide you. ## Timeline and Delivery Processing time not specified; expect 1-4 weeks based on similar programs. Delivery method not detailed—likely free shipping to home or doctor's office. Follow up by phone if delayed. Refills may require reauthorization. ## Alternatives if Denied or Ineligible - **$0 Copay Card** (commercial insurance): Reduces out-of-pocket to $0[1]. - **Other Glucagon Options**: Baqsimi nasal spray or generic kits (cheaper but less convenient). - **NeedyMeds/PAN Foundation**: General diabetes assistance. - **State Programs**: Check Medicaid expansion or local clinics. - **Manufacturer Copay Savings**: Xeris offers for insured patients. - **Discount Cards**: GoodRx for uninsured (may lower cost to $200-300). No biosimilar alternatives listed. ## Important Disclaimer This guide summarizes available info as of 2026. Eligibility, terms change—**always verify directly with Xeris at 1-877-694-8653**. Not medical/financial advice. Consult healthcare provider for treatment. Program availability not guaranteed; limited supply possible. Xeris not liable for application issues. *(Word count: 912)*

Program information last verified: March 30, 2026